Nobivac Canine 1-CV

Description

NOBIVAC® Canine 1-Cv is recommended for use in healthy dogs 6 weeks of age or older.

Uses and Benefits

• The virus has been inactivated and combined with an adjuvant designed to enhance the immune response
• Shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine coronavirus.

Useful Information

Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age. A second dose is given 2 to 4 weeks later. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended.

Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Use entire contents immediately.

WARNINGS:

• Contains gentamicin as a preservative.
• Vaccinate only healthy, non-parasitized dogs.
• Do not vaccinate pregnant bitches.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.